Sarepta Therapeutics Balance Sheet
SRPT / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Sarepta Therapeutics had $3.3B in total assets and $1.1B in shareholders' equity as of FY2025. Total debt was $141M against $801M in cash, resulting in a $661M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $801.3M | $1.1B | $428.4M | $2.1B | $2.1B | $835.1M | $370.8M | $370.8M | $599.7M | $122.4M | $80.3M | $73.6M | $257.0M | $187.7M | $39.9M |
| Accounts Receivable | $398.2M | $602.0M | $400.3M | $214.6M | $153.0M | $101.3M | $90.9M | $49.0M | $29.5M | $5.2M | $4.0M | $2.4M | $3.5M | $4.7M | $3.6M |
| Inventory | $914.7M | $750.0M | $322.9M | $204.0M | $186.2M | $232.0M | $171.4M | $125.4M | $83.6M | $12.8M | - | - | - | - | - |
| Current Assets | $2.5B | $3.1B | $2.6B | $2.6B | $2.6B | $2.5B | $1.5B | $1.4B | $1.2B | $373.5M | $224.5M | $247.8M | $270.8M | $193.9M | $45.2M |
| PP&E (Net) | $345.1M | $340.3M | $227.2M | $180.0M | $191.2M | $190.4M | $129.6M | $97.0M | $43.2M | $37.8M | $37.3M | $38.5M | $15.0M | $3.4M | $4.3M |
| Total Assets | $3.3B | $4.0B | $3.3B | $3.1B | $3.1B | $3.0B | $1.8B | $1.6B | $1.3B | $424.1M | $273.8M | $295.0M | $291.6M | $205.0M | $54.4M |
| Current Liabilities | $1.1B | $731.7M | $653.7M | $619.6M | $452.7M | $416.0M | $264.8M | $173.7M | $88.3M | $75.4M | $62.3M | $36.9M | $36.0M | $78.9M | $20.6M |
| Total Debt | $140.5M | $1.1B | $1.2B | $1.5B | $563.7M | - | - | $420.6M | $431.1M | $17.7M | $26.8M | $7.1M | $1.6M | $1.7M | $1.8M |
| Shareholders' Equity | $1.1B | $1.5B | $859.3M | $761.8M | $928.0M | $1.0B | $789.2M | $1.0B | $789.2M | $336.7M | $190.3M | $247.7M | $247.2M | $123.7M | $31.0M |